Bilateral Irreversible Amantadine-Related Corneal Edema Successfully Treated With Descemet Membrane Endothelial Keratoplasty (DMEK)
Eye Banking and Corneal Transplantation · 2023
DOI: 10.1097/ebct.0000000000000006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eye Banking and Corneal Transplantation, 2023. Verfasst von Patricia Beatriz Sierra und 1 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Corneal edema is a recognized adverse reaction of chronic amantadine hydrochloride use. Fortunately, it is usually reversible with prompt discontinuation of the medication. We report a case of a patient with schizoaffective disorder–bipolar treated with high doses of amantadine for drug-induced akathisia, who developed irreversible bilateral severe corneal edema, and was successfully treated with Descemet membrane endothelial keratoplasty (DMEK). This case highlights the importance of recognizing amantadine-induced endothelial toxicity and confirms the utility of DMEK in the treatment of the condition.
Zitieren
APA
Sierra, P. B., & Mendoza, M. S. (2023). Bilateral Irreversible Amantadine-Related Corneal Edema Successfully Treated With Descemet Membrane Endothelial Keratoplasty (DMEK). Eye Banking and Corneal Transplantation. https://doi.org/10.1097/ebct.0000000000000006
Vancouver
Sierra PB, Mendoza MS. Bilateral Irreversible Amantadine-Related Corneal Edema Successfully Treated With Descemet Membrane Endothelial Keratoplasty (DMEK). Eye Banking and Corneal Transplantation. 2023. doi:10.1097/ebct.0000000000000006
BibTeX
@article{Sierra2023,
author = {Sierra, Patricia Beatriz and Mendoza, Mariela Sierra},
title = {Bilateral Irreversible Amantadine-Related Corneal Edema Successfully Treated With Descemet Membrane Endothelial Keratoplasty (DMEK)},
journal = {Eye Banking and Corneal Transplantation},
year = {2023},
doi = {10.1097/ebct.0000000000000006}
}
EUVIMED